Unlocking Innovation: Exploiting the Untapped Potential of Pre-Clinical Support in Healthcare

The US spent over $792 billion on research and development in 2021. That figure has only soared since then and is expected to keep on the up over the coming decade. Unfortunately, as stakeholders channel more funds into R&D, a significant chunk of it ends up down the drain due to poor pre-clinical research. This preliminary stage of clinical research services is especially important for validating ideas and helping to explore solutions with the best chances of success. On the other hand, pre-clinical support services can also help to avoid wasting resources on less feasible drug concepts. Here’s a little bit more on how pre-clinical support can exploit untapped potential and accelerate innovation:  

At Rone Health, our primary focus is on personalized healthcare solutions tailored to meet your individual needs. We understand that each person’s requirements are distinct, which is why we offer a wide range of services addressing various health concerns, including sexual health, anti-aging treatments, and weight management.

Automation that frees up innovation

Isn’t seem to be a widely recognized or established entity in the health industry. It’s possible that it could be a new organization, a localized service, a startup, or a company that emerged after my last update.

The creativity and innovativeness of researchers are often tied up in iterative, non-intelligent tasks that come with preclinical research. As things stand, several large pharmaceutical players are still reliant upon legacy past-century processes riddled with these tasks. 

Besides requiring a lot of human intervention, these outdated systems may also not be able to accommodate emerging data sources on the fly. This further diminishes the chances of success during the clinical trial stage. 

Companies that offer clinical research services also provide digital transformation solutions that save researchers from the strain of these iterative tasks. They also afford experienced and knowledgeable teams that can handle these mundane errands, so researchers can shift their innovation elsewhere. 

The payoff is massive, resulting in the following positives for innovation: 

• Freeing up time and other resources
• Allowing workers to direct attention to higher-value work
• Boosting the efficiency of researchers

At Techindia, we off preclinical discovery support services that take care of all the tedious repetitive basics. From database management to monitoring data in the workflow, we take out major impediments to your pre-clinical research innovation.  

Augmenting human diligence with AI

Artificial intelligence continues to play a huge role in drug development. This intelligent technology can speed up the researcher’s ability to process data and pick out patterns therein that their human counterparts might take much longer to identify or possibly miss altogether. 

For instance, artificial intelligence can help inform trial design and even assist when it comes to optimization. Researchers have in the past relied on AI for data processing to determine: 

• The most appropriate patient loads or sample size
• Possible risks of the clinical trial
• Potential patient responses to drugs

All before drug development even makes it through to the human testing phase. That also translates to a lot of saved resources, ensuring these are channeled into highly feasible ideas only. 

Here at Techindia, our clinical trial care solutions leverage the power of intelligent technology for predictive modeling and shoring up data collection and analysis. Accurate data being the key driver of innovation, we ensure researchers get it right at the most critical stage. 

With preclinical data necessary for the FDA to green-light human trials, we can ensure robust and reliable data to back up efficacy and safety and help you get that approval. 

Access to a wider portfolio of skills

The more experienced minds you can get on deck for preclinical research, the better. It is the reality that many teams are struggling with a shortage of expertise. Research by the ASCP finds that there was a deficiency of more than 300,000 laboratory professionals in 2020. 

Preclinical support services can fill these gaps by augmenting in-house researchers with third-party experience. With clinical trials requiring specialized expertise across various elements, this becomes an even more important concern that could hold back innovation. Parts of the process that required special skill sets can be sorted out, so the rest of the pre-clinical trial phase can proceed with little to no downtime. 

But that’s not all. Your project also becomes more immune to other challenges such as staff absence due to leave, family emergencies, or unexpected turnover. Providing round-the-clock support, clinical care services support teams ensure such out-of-the-blues events don’t throw a spanner in the works. You can trust to have fail-safes that take into account what could go wrong, ensuring fewer bumps to efficiency and innovation. 

Quicker time to market to free up even more innovation

The average time-to-market for new drugs in 2023 is far from ideal, to say the least. A report by the N-SIDE finds that it could take up to a decade or more, which is off-putting for both sponsors and the pharma companies themselves. 

For investors, it means having to deal with amplified risk for an extended duration. For companies, it translates to years of resources and manpower on drug development that isn’t a surefire deal yet. Akin to putting all your eggs in just one basket. 

Preclinical support services can reduce the time it takes to go from the clinical trial and research stage to the actual market stage. The effect of that is unshackling more opportunities to innovate and test out other ideas without spending too much time on one idea with unknown chances of success. 

That said, here are a few ways that the right clinical research services can lower a drug’s time-to-market: 

• Early-stage drug development assistance helps to paint the full picture of a potential’s drug impact on human health, ensuring quicker responses from the FDA 
• Optimizing people, processes, and technology to streamline the workflow and ensure faster results
• Pre-clinical support can also accelerate the formulation of the study design, among other preliminaries that can also delay time-to-market

Many companies have gone on to cut their time to market by 50% just by way of offshore preclinical support. The result has been more time to test many other new ideas

Just 10% of drugs are a success

In other words, at least 9 in every 10 clinical trial drugs never see the light of day, either due to failing the human trial stage or getting shot down by regulators. It’s an alarming statistic but it is true. To beat the odds and ensure higher chances of success, pre clinical monitoring services are of the essence. Techindia offers the best pre clinical trial services to save you time and money, freeing more resources and manpower to drive innovation forward. Trust us to accelerate feasibility studies and bump your clinical trial innovation so you find profitable drug development opportunities with greater efficiency and certainty.